- Home
- NVS vs WFC Comparison
NVS vs WFC Comparison
Compare NVS & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVS
- WFC
- Stock Information
- Founded
- NVS 1895
- WFC 1852
- Country
- NVS Switzerland
- WFC United States
- Employees
- NVS N/A
- WFC 210821
- Industry
- NVS Biotechnology: Pharmaceutical Preparations
- WFC Major Banks
- Sector
- NVS Health Care
- WFC Finance
- Exchange
- NVS Nasdaq
- WFC Nasdaq
- Market Cap
- NVS 254.8B
- WFC 267.1B
- IPO Year
- NVS 1991
- WFC N/A
- Fundamental
- Price
- NVS $130.63
- WFC $85.95
- Analyst Decision
- NVS Sell
- WFC Buy
- Analyst Count
- NVS 3
- WFC 15
- Target Price
- NVS $118.00
- WFC $89.96
- AVG Volume (30 Days)
- NVS 1.7M
- WFC 14.9M
- Earning Date
- NVS 10-28-2025
- WFC 01-14-2026
- Dividend Yield
- NVS 1.99%
- WFC 2.10%
- EPS Growth
- NVS N/A
- WFC 26.82
- EPS
- NVS 7.30
- WFC 6.07
- Revenue
- NVS $56,372,000,000.00
- WFC $79,072,000,000.00
- Revenue This Year
- NVS $9.44
- WFC $8.81
- Revenue Next Year
- NVS $2.65
- WFC $5.15
- P/E Ratio
- NVS $17.88
- WFC $14.09
- Revenue Growth
- NVS 12.88
- WFC 1.54
- 52 Week Low
- NVS $96.06
- WFC $58.42
- 52 Week High
- NVS $134.00
- WFC $88.64
- Technical
- Relative Strength Index (RSI)
- NVS 56.19
- WFC 55.67
- Support Level
- NVS $123.24
- WFC $81.05
- Resistance Level
- NVS $133.19
- WFC $86.04
- Average True Range (ATR)
- NVS 1.78
- WFC 2.13
- MACD
- NVS 0.12
- WFC -0.13
- Stochastic Oscillator
- NVS 67.75
- WFC 63.24
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $2.0 trillion in balance-sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US market.